Titan Biotech jumps 5% on 1:4 bonus issue, dividend announcements
Titan Biotech shares have delivered multibagger returns, rising 208 per cent in one year and 536 per cent over five years.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.business-standard.com — the content belongs to Business Standard.
